Taken together, these results reveal that SF2535 efficaciously induces apoptosis through downregulating c-Myc and p-AKT pathways in primary B-ALL providing a rationale for further preclinical evaluation of PI3Kδ and BRD4 inhibition in B-ALL. This evidence concerns the gene BRD4 and acute lymphoblastic leukemia.